Psychedelic Drugs Market
Pharmaceuticals

Best Prospects In The Global Psychedelic Drugs Market And Strategies For Growth – Includes Psychedelic Drugs Market Trends

The Business Research Company’s report goes into great detail on the psychedelic drugs market size and growth, psychedelic drugs market regional analysis, psychedelic drugs market competitive landscape, and other critical information needed to excel in the psychedelic drugs industry.

 

Major players in the psychedelic drugs market include Johnson & Johnson, Pfizer, Hikma Pharmaceuticals PLC, Roche Holding AG, Merck & Co Inc, Jazz Pharmaceuticals plc, COMPASS Pathways PLC, Celon Pharma S.A., Numinus Wellness Inc, AbbVie, Mylan N.V., Avadel, NeuroRx Inc., Klarisana, AstraZeneca, Dr. Reddy’s Laboratories Ltd, Takeda Pharmaceutical Company Limited, Allergan Inc, Mota Ventures Corp., Seelos Therapeutics, Emmes Company, and Novatris International AG.

 

TBRC’s comprehensive market report based on extensive research will assist you in seamlessly devising your approaches in order to match key market player strategies.

 

The global psychedelic drugs market size is expected to grow from $3.62 billion in 2021 to $4.19 billion in 2022 at a compound annual growth rate (CAGR) of 15.6%. The global psychedelics market size is expected to reach $7.03 billion in 2026 at a CAGR of 14.2%.

 

North America was the largest region in the psychedelic drug market in 2021.

 

The psychedelic drug market consists of sales of psychedelic drugs by entities (organizations, sole traders, and partnerships) that are used to treat depression and post-traumatic stress disorder and also help with mental health diagnoses. Psychedelic drugs refer to hallucinogens. These drugs are a group of substances that usually alter and enhance perception, thinking processes, energy levels, and promote mental experiences. These include chemicals such as Lysergic acid diethylamid (LSD) and plants such as peyote. These medications are used to treat a variety of brain conditions.

 

The increase in the cases of mental illnesses is expected to propel the growth of the psychedelic drug market going forward.

 

Request a Sample of the Global Psychedelic Drugs Market Report

 

Psychedelic Drugs Market
Psychedelic Drugs Market

 

The introduction of depression spray is the key trend gaining popularity in the psychedelic drug market. Major companies operating in the psychedelic drug market are introducing nasal-spray drugs for major depressive disorders to sustain their position in the market.

 

TBRC’s global psychedelic drugs market report is segmented:
By Type: Lysergic Acid Diethylamid (LSD), Ketamine, Phencyclidine, Gamma Hydroxybutyric Acid (GHB), Salvia

By Disease Indication: Depression, PTSD

By Origin: Natural, Synthetic

By Application: Treatment-Resistant Depression, Opiate Addiction, Post-Traumatic Stress Disorder, Narcolepsy, Panic Disorders

By Distribution Channel: Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy

By Geography: North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa.

 

The Psychedelic Drugs Global Market Report 2022 is one of a series of new reports from The Business Research Company that provides an overview of the psychedelic drugs market globally and regionally, analyzes and forecasts market size, share, psychedelic drugs market players, psychedelic drugs market segments, leading competitor revenues, profiles and market shares.

 

Here Is A List Of Similar Reports From The Business Research Company:

Antidepressants Global Market Report 2022

Bipolar Disorder Therapeutics Global Market Report 2022

Healthcare Services Global Market Report 2022

 

Interested To Know More About The Business Research Company?

The Business Research Company has published over 1000 industry reports, covering over 2500 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.

 

Read more about us at https://www.thebusinessresearchcompany.com/about-the-business-research-company.aspx

 

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow us on LinkedIn: https://in.linkedin.com/company/the-business-research-company
Follow us on Twitter: https://twitter.com/tbrc_info
Check out our Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *